Study to Improve Partner Services for STD Prevention
Prospective Study for Cost-Effectiveness Strategies to Improve Partner Notification: Female Trichomonas and Male Urethritis Studies
2 other identifiers
interventional
1,500
1 country
2
Brief Summary
The goal of this study was to examine the efficacy of patient-delivered partner treatment (PDPT) compared to standard partner referral (PR) and booklet enhanced partner referral (BEPR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Dec 2001
Typical duration for phase_2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedSeptember 21, 2005
September 1, 2005
September 13, 2005
September 13, 2005
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Index patient report of partner taking medicine at 6-8 weeks
Secondary Outcomes (2)
Index patient re-infection at 6-8 weeks
Cost effectiveness outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Woman attending Family Planning Clinic or men attending STD clinic
- Aged 16-44
- (non-pregnant women) - positive InPouch for trichomonas, or
- (pregnant women) - positive wet mount or InPouch for Trichomonas vaginalis
- (men) a complaint of urethritis which is verified on examination
- Report having \>= 1sex partners in past 60 days
- Not presumptively treated for trichomonas (women) or urethritis (men)
- Provide informed consent to be re-contacted by telephone or in person in 14-28 days for a follow-up interview and T vaginalis or CT/GC rescreening
You may not qualify if:
- Men
- Prisoner
- Has taken cefixime or azithromycin in last two weeks
- Has previously participated in the study
- All female partners are pregnant and did not have male partners Women
- client has taken metronidazole in the last two weeks
- client has been in this study previously
- women who are asymptomatic and in their first trimester of pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centers for Disease Control and Preventionlead
- Tulane Universitycollaborator
Study Sites (2)
Delgado STD Clinic
New Orleans, Louisiana, 99999, United States
Orleans Women's Health Clinic
New Orleans, Louisiana, 99999, United States
Related Publications (1)
Kissinger P, Mohammed H, Richardson-Alston G, Leichliter JS, Taylor SN, Martin DH, Farley TA. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis. 2005 Sep 1;41(5):623-9. doi: 10.1086/432476. Epub 2005 Jul 19.
PMID: 16080084RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patty Kissinger, PhD
Tulane University School of Public Health and Tropical Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
December 1, 2001
Study Completion
December 1, 2004
Last Updated
September 21, 2005
Record last verified: 2005-09